[1]
“Intravenous Lidocaine for Opioid-Resistant Pain Control in Metastatic Breast Cancer”, acmcr, vol. 5, no. 1, pp. 151–155, Jan. 2021, Accessed: Sep. 08, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22458